~~<i id='7988492C56'><strike id='7988492C56'><tt id='7988492C56'><pre id='7988492C56'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

entertainment

leisure time

author：fashion 2025-09-06 01:59:04 - browse：497

Adam's take main illustration — Molly Ferguson/STAT

Biotech is awash in PIPEs.

The numbers behind these privately negotiated purchases of public-company stock are astounding. By my count, there have been 30 PIPE transactions involving public biotechs and institutional investors (mostly hedge funds) that have raised $4 billion in the first two months of the year.

Just this week, five biotechs have brought in a combined $950 million via PIPEs, including Denali Therapeutics raising $500 million, the largest such financing this year. Crinetics Pharmaceuticals raised $350 million.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medical leaders decry Supreme Court decision on affirmative action
Next article： Questions and answers about ramping up H5N1 bird flu vaccine

knowledge

focus

Wikipedia

leisure time

focus

AdobeThisarticleisadaptedfromSTAT’sexclusiveanalysisintheSTATReport: “Climaterankings:Howtopdrugcomp

WSS

Liver decline slowed by off

Listen: A conversation with researcher Kevin Esvelt on biosecurity

Reports of telehealth's death have been greatly exaggerated

Eyeing GLP

The Readout: Biogen, Guardant, AstraZeneca, H5N1 vaccine

FDA poised to publish guidelines for clinical trial diversity

entertainment

leisure time

knowledge

How to save PrEP access — and even expand it

Cytokinetics CEO Robert Blum is on my Worst CEO shortlist again

Psychedelics group wrestles with new pharma identity

Flu, Covid vaccination rates decline, new survey data show

Alkermes shareholders re

6 solutions to address cancer drug shortages and others

Virginia high school admissions case could be legal follow

FDA poised to publish guidelines for clinical trial diversity

Peter Hotez and the public health issue of online harassment

Cue Health, Covid

knowledge

IVG is promising — but it won’t replace IVF quite yet

At flashy new research hub, AstraZeneca lays out ambitious growth goals

Addressing health care workers' trauma can help fight burnout

What will Novo Nordisk's VC do with its influx of cash?

Flu, Covid vaccination rates decline, new survey data show

Digital health: a case of mistaken identity

focus

Wikipedia

leisure time

focus